Blood-Based Colorectal Cancer Screening Test Gets Thumbs Up From FDA

The FDA has approved Guardant’s Shield blood test for colorectal cancer (CRC) screening in adults aged 45 and older who are at average risk for the disease.
Source: Drug Industry Daily